\
&
Contact us
\
&
Contact us
This was 5 years ago
LocationBuilding ELLIPS
Koning Albert II- laan 35, 1030 Brussel
This information session is organised by the European Commission in close cooperation with the Belgian Legal and Financial National Contact Points.
The aim of the event is to explain to Horizon 2020 project partners how to avoid errors in Horizon 2020 project reporting. We will close the day by some info on the implementation of the next framework programme for research and innovation, Horizon Europe.
This event was originally planned on 21 April and is postponed to 17 June. From the moment it is certain that it can take place, we will open the registrations.
Link to event website: here
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
